Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANTEOTECH LTD Capital/Financing Update 2013

Jul 8, 2013

64304_rns_2013-07-08_84e39846-6f03-4058-a23a-1fc1782f604e.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [209 x 115] intentionally omitted <==

9[th ] July 2013

Company Announcements Office Australian Stock Exchange Level 6, 20 Bridge Street Sydney NSW 2000

ASX Announcement

"Anteo awarded $1.7M Early Stage Commercialisation Grant" BRR webcast”

ANTEO DIAGNOSTICS LIMITED (ASX: ADO) has released a webcast with the following details:

Anteo awarded $1.7M Early Stage Commercialisation Grant

Speaker: Dr Geoffrey Cumming, CEO

Live date: Mon, 9 Jul 2013 9:30am AEST Access this webcast at www.brrmedia.com/event/112965

Access other ADO webcasts at www.brrmedia.com/asx/ADO

ENDS

For More Information Contact:

Dr Geoff Cumming, CEO Anteo Diagnostics Limited Tel: +61 2 8823 3110

Sam Sloane Six Degrees Investor Relations Tel: +61 2 9230 0661

Anteo Diagnostics Limited ABN 78 090 487 273 Unit 4, 26 Brandl Street, Eight Mile Plains Qld 4113 Phone 07 3219 0085 Fax 07 3219 0553 Email [email protected] Web www.anteodx.com